Sign In
Buy CVSI
$0.0272
-0.0025 (-8.48%)
At Close: Jun 03, 2026
CV Sciences, Inc. (CVSI) Shareholder/Analyst Call Prepared Remarks Transcript
03:01pm, Tuesday, 02'nd Jun 2026
CV Sciences, Inc. (CVSI) Shareholder/Analyst Call Prepared Remarks Transcript
CV Sciences, Inc. (CVSI) Q1 2026 Earnings Call Prepared Remarks Transcript
06:50pm, Thursday, 14'th May 2026
CV Sciences, Inc. (CVSI) Q1 2026 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026
06:00pm, Tuesday, 12'th May 2026
SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extract
CV Sciences, Inc. (CVSI) Q4 2025 Earnings Call Prepared Remarks Transcript
06:16pm, Thursday, 26'th Mar 2026
CV Sciences, Inc. (CVSI) Q4 2025 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results
04:00pm, Thursday, 26'th Mar 2026
SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extra
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026
05:00pm, Tuesday, 24'th Mar 2026
SAN DIEGO, CA / ACCESS Newswire / March 24, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extra
CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth
05:00pm, Tuesday, 10'th Mar 2026
SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, sc
CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness
08:30am, Thursday, 26'th Feb 2026
With 20g of clean protein, 5g of creatine, and LactoSpore® probiotics, Empowr supports everyday strength, mental energy and digestive balance without dairy or added sugar. Simple, functional nutritio
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD
07:00pm, Monday, 22'nd Dec 2025
SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex
CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call Prepared Remarks Transcript
06:01pm, Thursday, 13'th Nov 2025
CV Sciences, Inc. (OTCQB:CVSI) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Brendan Hawkins Joseph Dowling - CEO, Secretary & Director Joerg Grasser - Chief Financial Offic
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results
04:00pm, Thursday, 13'th Nov 2025
SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
06:15pm, Monday, 10'th Nov 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in
CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus
09:00pm, Tuesday, 26'th Aug 2025
Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond. SAN DIEGO, CALIFORNIA / ACCE
CV Sciences, Inc. (CVSI) Q2 2025 Earnings Call Transcript
03:11am, Wednesday, 20'th Aug 2025
CV Sciences, Inc. (OTCQB:CVSI) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Brendan Hawkins - Corporate Participant Investor Relations - Corporate Participant Joerg
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
04:00pm, Wednesday, 13'th Aug 2025
SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extr
